Results 211 to 220 of about 19,494 (244)
Some of the next articles are maybe not open access.
Anthropometric correlates of FeNO in healthy children
7.6 Paediatric Respiratory Epidemiology, 2015Introduction: Published evidence regarding anthropometric determinants of FeNO in children is inconclusive. This factor may hamper the interpretation of FeNO measurements in respiratory epidemiology. Objective: The aim of the study was to establish relationship of FeNO with age, height, weight and chest circumferences in healthy children aged 7-9 ...
Kamil Baranski, Jan Eugeniusz Zejda
openaire +1 more source
European Respiratory Journal, 2011
Background: Exhaled nitric oxide (FeNO) is a validated non-invasive biomarker of airways inflammation that is easy to measure, and gives immediate results. Its use has been increasing recently in routine care. Several individual factors that affect FeNO values have been identified, including age, height, weight,
Tiago Jacinto +5 more
openaire +1 more source
Background: Exhaled nitric oxide (FeNO) is a validated non-invasive biomarker of airways inflammation that is easy to measure, and gives immediate results. Its use has been increasing recently in routine care. Several individual factors that affect FeNO values have been identified, including age, height, weight,
Tiago Jacinto +5 more
openaire +1 more source
Assessment of SLIT efficacy in children by FeNO
7.2 Paediatric Asthma and Allergy, 2015Background: Although the sublingual allergen specific immunotherapy (SLIT) has been of great scientific interest for the last decades, we are still looking for a good feasible parameter in the assessment of clinical efficacy, apart of the conventional methods such as peak flow measurement, spirometry and symptom assessments (clinical scores).
Zorica Zivkovic +3 more
openaire +1 more source
Fraktioniertes exhaliertes Stickstoffmonoxid (FeNO)
Atemwegs- und Lungenkrankheiten, 2021Y. Salem Mahmoud +3 more
openaire +1 more source
Utility of FeNO in differentiating ACO and COPD
Monitoring airway disease, 2019Introduction: ACO is a disease entity which warrants early screening and isolation from COPD for which FeNO is a useful tool, we are the first to attempt the same in Indian population Aim: To assess the contribution of FeNO in differentiating ACO from COPD in patients with persistent airflow limitation Objectives: 1) Assess FeNO levels in patients ...
openaire +1 more source
FeNO in different asthma phenotypes
2009[No abstract available]
Gemicioglu, B., Guven, K., Dogan, I
openaire +1 more source
Checking Zero Calibration of the HypAir FeNO
American Journal of Respiratory and Critical Care Medicine, 2010Lodge, CJ +5 more
openaire +3 more sources

